NCT05563363

Brief Summary

Home Treatment (HT) has been successfully implemented in adult psychiatry in several countries including Switzerland. Patients with addiction problems were generally excluded even if the latter was not the main diagnosis. On the other hand, community treatments have successfully been established for these individuals. The investigators have recently offered HT to persons with severe addictive disorders which was well accepted. The investigators intend to conduct a pilot study to prepare a large-scale study if successful. The investigators intend to compare HT to treatment as usual (regular inpatient treatment) on a specialized ward with respect to readmission rates during 6 months after discharge. The data show that 70.8% of all readmissions occur during the first 6 months. Therefore, a period of 6 months is considered an adequate time interval to sufficiently answer this pilot study's question.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
1mo left

Started Dec 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
Dec 2022May 2026

First Submitted

Initial submission to the registry

September 23, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 3, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

December 1, 2022

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2026

Expected
Last Updated

August 28, 2025

Status Verified

August 1, 2025

Enrollment Period

3.1 years

First QC Date

September 23, 2022

Last Update Submit

August 21, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • readmission rates

    Number of readmissions to hospital during the 6 months following discharge

    6 month post-discharge

Secondary Outcomes (5)

  • time to readmission

    6 months

  • length of hospitalization

    6 months

  • number of emergency room visits

    6 months

  • clinical outcome

    6 months

  • patient satisfaction

    6 months

Study Arms (2)

Home treatment

EXPERIMENTAL

Home visits by care staff at the same frequency as in hospital

Other: Hospital-like treatment in patients' home

Standard inpatient treatment

ACTIVE COMPARATOR

Inpatient treatment on hospital ward

Other: standard inpatient treatment

Interventions

Hospital-like treatment in patients' home. Caregivers, medical doctors and social workers will make several visits per day to the patients' home. 24/7 contact is available.

Home treatment

Inpatient treatment on addiction ward

Standard inpatient treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Substance use disorder
  • age 18 or above
  • sufficient french language skills
  • competent subjects
  • consent to randomization progress

You may not qualify if:

  • organic brain disease or developmental disorder
  • non voluntary admission
  • severe somatic comorbidity
  • History of complicated substance withdrawal
  • acute suicidal ideation
  • aggressive behavior
  • acute psychiatric disease such as mania or psychosis
  • distance to center (must be reachable within 60 minutes)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Geneva University Hospital

Geneva, Switzerland

RECRUITING

MeSH Terms

Conditions

Substance-Related Disorders

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Central Study Contacts

Louise Penzenstadler, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Pilot study, randomized, open, non-blinded
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

September 23, 2022

First Posted

October 3, 2022

Study Start

December 1, 2022

Primary Completion

December 31, 2025

Study Completion (Estimated)

May 31, 2026

Last Updated

August 28, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations